Finerenone consistently reduces heart failure events and cardiovascular death regardless of ischemic heart disease history, according to the FINEARTS-HF trial.
Jawad Butt, MD, PhD
Advertisement
Articles by Jawad Butt, MD, PhD
Jawad Butt, MD, offers insight into his analysis of the FINEARTS-HF trial.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
FDA Approves Camizestrant for ESR1-Mutated Breast Cancer
3
FDA Expands Accelerated Approval of Sevabertinib to First-Line HER2-Mutant NSCLC
4
Community Pharmacy Can Win and Still Lose
5